Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C004822 |
10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide |
[EPHX1 gene SNP affects the metabolism of carbamazepine epoxide] which affects the chemical synthesis of 10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide | affects chemical synthesis|affects metabolic processing | 15692831
|
C004822 |
10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide |
[EPHX1 protein results in increased metabolism of carbamazepine epoxide] which results in increased chemical synthesis of 10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide | increases chemical synthesis|increases metabolic processing | 15692831
|
C026486 |
1,2,5,6-dibenzanthracene |
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] | increases metabolic processing|increases reaction | 8961944
|
C026486 |
1,2,5,6-dibenzanthracene |
EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] | increases metabolic processing|increases reaction | 8961944
|
C026486 |
1,2,5,6-dibenzanthracene |
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] | increases metabolic processing|increases reaction | 8961944
|
C026486 |
1,2,5,6-dibenzanthracene |
EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] | increases metabolic processing|increases reaction | 8961944
|
C012277 |
1,2-diamino-4-nitrobenzene |
1,2-diamino-4-nitrobenzene results in increased expression of EPHX1 mRNA | increases expression | 17070881
|
C031763 |
1,3-butadiene |
EPHX1 5' UTR polymorphism results in increased susceptibility to 1,3-butadiene | increases response to substance | 15716486
|
C031763 |
1,3-butadiene |
EPHX1 gene polymorphism results in increased susceptibility to 1,3-butadiene | increases response to substance | 12605384 11238181
|
C031763 |
1,3-butadiene |
GSTM1 gene polymorphism promotes the reaction [EPHX1 gene polymorphism results in increased susceptibility to 1,3-butadiene] | increases reaction|increases response to substance | 11238181
|
C031763 |
1,3-butadiene |
GSTT1 gene polymorphism promotes the reaction [EPHX1 gene polymorphism results in increased susceptibility to 1,3-butadiene] | increases reaction|increases response to substance | 11238181
|
C031763 |
1,3-butadiene |
EPHX1 gene mutant form results in increased susceptibility to 1,3-butadiene | increases response to substance | 16730686 12929123
|
C038983 |
1,3-dimethylthiourea |
1,3-dimethylthiourea results in increased expression of EPHX1 mRNA | increases expression | 10190572
|
C038983 |
1,3-dimethylthiourea |
1,3-dimethylthiourea results in increased expression of EPHX1 protein | increases expression | 10190572
|
C035314 |
1-nitropropane |
1-nitropropane results in decreased expression of EPHX1 mRNA | decreases expression | 17070881
|
C063002 |
2,3-dimethoxy-1,4-naphthoquinone |
2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of EPHX1 mRNA | decreases expression | 17547211
|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of EPHX1 mRNA | increases expression | 17070881
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of EPHX1 mRNA | affects expression | 21346803
|
C025235 |
2,6-diaminotoluene |
2,6-diaminotoluene results in decreased expression of EPHX1 mRNA | decreases expression | 17070881
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of EPHX1 mRNA | affects expression | 21346803
|
C014706 |
2-nitro-4-phenylenediamine |
2-nitro-4-phenylenediamine results in increased expression of EPHX1 mRNA | increases expression | 17070881
|
C019499 |
2-nitrofluorene |
2-nitrofluorene results in increased expression of EPHX1 mRNA | increases expression | 14600272 15890375
|
C016617 |
2-nitropropane |
2-nitropropane results in increased expression of EPHX1 mRNA | increases expression | 17070881
|
C028676 |
4-acetylaminofluorene |
4-acetylaminofluorene results in increased expression of EPHX1 mRNA | increases expression | 17070881
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of EPHX1 mRNA | affects expression | 21346803
|
C016583 |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of EPHX1 mRNA | increases expression | 14600272 15890375
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of EPHX1 mRNA | affects expression | 17562736 15606129
|
D000082 |
Acetaminophen |
[Acetaminophen results in increased activity of and results in increased localization of NFE2L2 protein] which results in increased expression of EPHX1 mRNA | increases activity|increases expression|increases localization | 15122755
|
D016604 |
Aflatoxin B1 |
EPHX1 gene SNP affects the susceptibility to Aflatoxin B1 | affects response to substance | 12907637
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 results in increased expression of EPHX1 mRNA | increases expression | 15890375 14600272
|
D000348 |
Aflatoxins |
EPHX1 gene polymorphism results in increased susceptibility to Aflatoxins | increases response to substance | 15734960
|
C040534 |
alpha-hexachlorocyclohexane |
alpha-hexachlorocyclohexane results in increased expression of EPHX1 mRNA | increases expression | 16940010
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of EPHX1 mRNA | affects expression | 16483693
|
C526219 |
apple polyphenol extract |
apple polyphenol extract results in decreased expression of EPHX1 mRNA | decreases expression | 16369997
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of EPHX1 mRNA | decreases expression | 17547211
|
C015001 |
arsenite |
arsenite results in increased expression of EPHX1 mRNA | increases expression | 18929588
|
C015001 |
arsenite |
TRP53 protein affects the reaction [arsenite results in increased expression of EPHX1 mRNA] | affects reaction|increases expression | 18929588
|
D001194 |
Asbestos |
EPHX1 gene polymorphism affects the susceptibility to Asbestos | affects response to substance | 17159790
|
D001194 |
Asbestos |
EPHX1 protein affects the susceptibility to Asbestos | affects response to substance | 15993904
|
D001205 |
Ascorbic Acid |
[Quercetin co-treated with Ascorbic Acid] results in decreased expression of EPHX1 mRNA | affects cotreatment|decreases expression | 17639512
|
C030935 |
benz(a)anthracene |
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of benz(a)anthracene] | increases metabolic processing|increases reaction | 8961944
|
C030935 |
benz(a)anthracene |
EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benz(a)anthracene] | increases metabolic processing|increases reaction | 8961944
|
C030935 |
benz(a)anthracene |
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of benz(a)anthracene] | increases metabolic processing|increases reaction | 8961944
|
C030935 |
benz(a)anthracene |
EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benz(a)anthracene] | increases metabolic processing|increases reaction | 8961944
|
D001554 |
Benzene |
EPHX1 protein results in increased metabolism of Benzene | increases metabolic processing | 17885617
|
D001554 |
Benzene |
EPHX1 protein affects the reaction [Benzene results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 12655032
|
D001554 |
Benzene |
EPHX1 protein affects the susceptibility to Benzene | affects response to substance | 12655032
|
D001554 |
Benzene |
Benzene affects the expression of EPHX1 mRNA | affects expression | 15878777
|
C015700 |
benzo-1,2,3-thiadiazole |
benzo-1,2,3-thiadiazole results in increased expression of EPHX1 mRNA | increases expression | 8951341
|
C023393 |
benzo(a)pyrene 7,8-oxide |
CYP2C11 protein promotes the reaction [EPHX1 protein affects the hydrolysis of benzo(a)pyrene 7,8-oxide] | affects hydrolysis|increases reaction | 12051674
|
C002615 |
benzo(c)phenanthrene |
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of benzo(c)phenanthrene] | increases metabolic processing|increases reaction | 8961944
|
C002615 |
benzo(c)phenanthrene |
EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benzo(c)phenanthrene] | increases metabolic processing|increases reaction | 8961944
|
C002615 |
benzo(c)phenanthrene |
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of benzo(c)phenanthrene] | increases metabolic processing|increases reaction | 8961944
|
C002615 |
benzo(c)phenanthrene |
EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benzo(c)phenanthrene] | increases metabolic processing|increases reaction | 8961944
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of EPHX1 mRNA | increases expression | 15735009
|
D001564 |
Benzo(a)pyrene |
EPHX1 protein polymorphism affects the metabolism of and results in increased activity of Benzo(a)pyrene | affects metabolic processing|increases activity | 15298956
|
D001564 |
Benzo(a)pyrene |
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of Benzo(a)pyrene] | increases metabolic processing|increases reaction | 8961944
|
D001564 |
Benzo(a)pyrene |
EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of Benzo(a)pyrene] | increases metabolic processing|increases reaction | 8961944
|
D001564 |
Benzo(a)pyrene |
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of Benzo(a)pyrene] | increases metabolic processing|increases reaction | 8961944
|
D001564 |
Benzo(a)pyrene |
EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of Benzo(a)pyrene] | increases metabolic processing|increases reaction | 8961944
|
C005465 |
benzothiazole |
benzothiazole results in increased expression of EPHX1 mRNA | increases expression | 8951341
|
C032036 |
bromobenzene |
bromobenzene results in increased expression of EPHX1 mRNA | increases expression | 12628495
|
D002104 |
Cadmium |
Cadmium results in increased expression of EPHX1 mRNA | increases expression | 17327699
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in increased expression of EPHX1 mRNA | increases expression | 17327699
|
D002220 |
Carbamazepine |
Carbamazepine results in increased expression of EPHX1 mRNA | increases expression | 17112801
|
D002220 |
Carbamazepine |
EPHX1 gene SNP affects the susceptibility to Carbamazepine | affects response to substance | 19620853
|
C012227 |
carbamazepine epoxide |
[EPHX1 gene SNP affects the metabolism of carbamazepine epoxide] which affects the chemical synthesis of 10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide | affects chemical synthesis|affects metabolic processing | 15692831
|
C012227 |
carbamazepine epoxide |
[EPHX1 protein results in increased metabolism of carbamazepine epoxide] which results in increased chemical synthesis of 10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide | increases chemical synthesis|increases metabolic processing | 15692831
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of EPHX1 mRNA | decreases expression | 17484886
|
D002330 |
Carmustine |
Carmustine results in decreased expression of EPHX1 mRNA | decreases expression | 15980968
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of EPHX1 mRNA | increases expression | 17851650
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of EPHX1 mRNA | increases expression | 18178546
|
C031180 |
chrysene |
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of chrysene] | increases metabolic processing|increases reaction | 8961944
|
C031180 |
chrysene |
EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of chrysene] | increases metabolic processing|increases reaction | 8961944
|
C031180 |
chrysene |
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of chrysene] | increases metabolic processing|increases reaction | 8961944
|
C031180 |
chrysene |
EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of chrysene] | increases metabolic processing|increases reaction | 8961944
|
D002994 |
Clofibrate |
Clofibrate results in decreased activity of EPHX1 protein | decreases activity | 10528994
|
D003520 |
Cyclophosphamide |
Cyclophosphamide affects the expression of EPHX1 mRNA | affects expression | 18246545
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in increased expression of EPHX1 mRNA | increases expression | 18246545
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of EPHX1 mRNA | decreases expression | 20106945
|
D015084 |
2,4-Dichlorophenoxyacetic Acid |
2,4-Dichlorophenoxyacetic Acid results in increased activity of EPHX1 protein | increases activity | 3032197
|
C014347 |
decitabine |
decitabine results in increased expression of EPHX1 mRNA | increases expression | 19194470
|
C007262 |
deoxynivalenol |
deoxynivalenol results in decreased expression of EPHX1 mRNA | decreases expression | 15371230
|
C061481 |
dibenzoylmethane |
dibenzoylmethane results in increased expression of EPHX1 mRNA | increases expression | 17942926
|
C061481 |
dibenzoylmethane |
[sulforafan co-treated with dibenzoylmethane] results in increased expression of EPHX1 mRNA | affects cotreatment|increases expression | 17942926
|
D002945 |
Cisplatin |
Cisplatin affects the expression of EPHX1 mRNA | affects expression | 18246545
|
D002945 |
Cisplatin |
Cisplatin results in increased expression of EPHX1 mRNA | increases expression | 18246545
|
C121718 |
dicyclanil |
dicyclanil results in increased expression of EPHX1 mRNA | increases expression | 15664270
|
D004051 |
Diethylhexyl Phthalate |
Diethylhexyl Phthalate results in decreased activity of EPHX1 protein | decreases activity | 10528994
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of EPHX1 mRNA | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of EPHX1 mRNA] | decreases reaction|increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX1 mRNA | affects cotreatment|decreases expression | 18544905
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX1 mRNA | affects cotreatment|increases expression | 18544905
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of EPHX1 mRNA | increases expression | 17602206 19638242 20360939
|
D004052 |
Diethylnitrosamine |
[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of EPHX1 protein | affects cotreatment|increases expression | 20935162
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of EPHX1 mRNA | increases expression | 15890375
|
C035318 |
diethylthiourea |
diethylthiourea results in increased expression of EPHX1 mRNA | increases expression | 10190572
|
C035318 |
diethylthiourea |
diethylthiourea results in increased expression of EPHX1 protein | increases expression | 10190572
|
D015127 |
9,10-Dimethyl-1,2-benzanthracene |
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] | increases metabolic processing|increases reaction | 8961944
|
D015127 |
9,10-Dimethyl-1,2-benzanthracene |
EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] | increases metabolic processing|increases reaction | 8961944
|
D015127 |
9,10-Dimethyl-1,2-benzanthracene |
EPHX1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene | affects response to substance | 15331171
|
D015127 |
9,10-Dimethyl-1,2-benzanthracene |
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] | increases metabolic processing|increases reaction | 8961944
|
D015127 |
9,10-Dimethyl-1,2-benzanthracene |
EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] | increases metabolic processing|increases reaction | 8961944
|
D015127 |
9,10-Dimethyl-1,2-benzanthracene |
EPHX1 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene | increases response to substance | 11323178
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in increased expression of EPHX1 mRNA | increases expression | 15890375 14600272
|
C032788 |
diphenylthiourea |
diphenylthiourea results in increased expression of EPHX1 mRNA | increases expression | 10190572
|
C032788 |
diphenylthiourea |
diphenylthiourea results in increased expression of EPHX1 protein | increases expression | 10190572
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of EPHX1 mRNA | increases expression | 15205334
|
D004391 |
Dust |
Dust results in decreased expression of EPHX1 mRNA | decreases expression | 17805423
|
C007366 |
erythritol anhydride |
EPHX1 gene polymorphism affects the susceptibility to erythritol anhydride | affects response to substance | 15036125
|
C007366 |
erythritol anhydride |
EPHX1 gene mutant form results in increased susceptibility to erythritol anhydride | increases response to substance | 12929123
|
D004958 |
Estradiol |
Estradiol affects the expression of EPHX1 mRNA | affects expression | 14699072
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of EPHX1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of EPHX1 mRNA | decreases expression | 16174780
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of EPHX1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of EPHX1 mRNA | affects cotreatment|decreases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of EPHX1 mRNA | decreases expression | 16174780
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of EPHX1 mRNA | increases expression | 16926038
|
D005027 |
Ethylene Oxide |
EPHX1 protein affects the metabolism of Ethylene Oxide | affects metabolic processing | 11437638
|
D005027 |
Ethylene Oxide |
EPHX1 protein affects the metabolism of Ethylene Oxide | affects metabolic processing | 11437638
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased expression of EPHX1 mRNA | increases expression | 15954086
|
C017690 |
fenvalerate |
fenvalerate metabolite results in increased activity of EPHX1 protein | increases activity | 10630566
|
D015073 |
2-Acetylaminofluorene |
2-Acetylaminofluorene results in increased expression of EPHX1 mRNA | increases expression | 17317680
|
D015073 |
2-Acetylaminofluorene |
2-Acetylaminofluorene results in increased expression of EPHX1 mRNA | increases expression | 17070881
|
D005472 |
Fluorouracil |
EPHX1 protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of EPHX1 mRNA | increases expression | 15205334
|
C056933 |
fumonisin B1 |
fumonisin B1 results in increased expression of EPHX1 mRNA | increases expression | 16221962
|
D019833 |
Genistein |
Genistein results in increased expression of EPHX1 mRNA | increases expression | 18847459
|
D005978 |
Glutathione |
Glutathione deficiency results in increased expression of EPHX1 mRNA | increases expression | 15345336
|
C071834 |
glycidamide |
glycidamide results in increased expression of EPHX1 mRNA | increases expression | 17822822
|
C071834 |
glycidamide |
glycidamide results in increased expression of EPHX1 protein | increases expression | 17822822
|
C010176 |
halofuginone |
halofuginone results in increased expression of EPHX1 mRNA | increases expression | 17180598
|
D006581 |
Hexachlorobenzene |
Hexachlorobenzene results in increased expression of EPHX1 mRNA | increases expression | 15159207
|
D006841 |
Hydrocarbons, Aromatic |
EPHX1 protein affects the metabolism of Hydrocarbons, Aromatic | affects metabolic processing | 12359356
|
C011890 |
kojic acid |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX1 mRNA | affects cotreatment|decreases expression | 18544905
|
C011890 |
kojic acid |
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX1 mRNA | affects cotreatment|increases expression | 18544905
|
D017258 |
Medroxyprogesterone Acetate |
ESR1 protein promotes the reaction [Medroxyprogesterone Acetate results in increased expression of EPHX1 protein] | increases expression|increases reaction | 20383792
|
D017258 |
Medroxyprogesterone Acetate |
Medroxyprogesterone Acetate results in increased expression of EPHX1 mRNA | increases expression | 20383792
|
D017258 |
Medroxyprogesterone Acetate |
Medroxyprogesterone Acetate results in increased expression of EPHX1 protein | increases expression | 20383792
|
D008701 |
Methapyrilene |
Methapyrilene results in increased expression of EPHX1 mRNA | increases expression | 15890375
|
D016566 |
Organoselenium Compounds |
Organoselenium Compounds results in increased activity of EPHX1 protein | increases activity | 17163488
|
D010126 |
Ozone |
Ozone results in decreased expression of EPHX1 mRNA | decreases expression | 12763052
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid affects the expression of EPHX1 mRNA | affects expression | 18281256
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of EPHX1 mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of EPHX1 mRNA | increases expression | 19482888
|
D010634 |
Phenobarbital |
[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of EPHX1 protein | affects cotreatment|increases expression | 20935162
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of EPHX1 mRNA | increases expression | 16940010
|
D010672 |
Phenytoin |
EPHX1 gene polymorphism affects the susceptibility to Phenytoin | affects response to substance | 19952982
|
D010672 |
Phenytoin |
EPHX1 protein results in increased metabolism of Phenytoin | increases metabolic processing | 19952982
|
D010795 |
Phthalic Acids |
Phthalic Acids results in decreased expression of EPHX1 mRNA | decreases expression | 15728792
|
D010882 |
Piperonyl Butoxide |
Piperonyl Butoxide results in increased expression of EPHX1 mRNA | increases expression | 15890375
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of EPHX1 mRNA | increases expression | 16221962 15375163 17426115
|
C006253 |
pirinixic acid |
PPARA protein affects the reaction [pirinixic acid results in increased expression of EPHX1 mRNA] | affects reaction|increases expression | 16221962
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of EPHX1 mRNA | increases expression | 15890375
|
D011084 |
Polycyclic Hydrocarbons, Aromatic |
EPHX1 gene polymorphism affects the susceptibility to Polycyclic Hydrocarbons, Aromatic | affects response to substance | 15466980 15061915
|
D011084 |
Polycyclic Hydrocarbons, Aromatic |
EPHX1 protein polymorphism affects the susceptibility to Polycyclic Hydrocarbons, Aromatic | affects response to substance | 15355699
|
D011084 |
Polycyclic Hydrocarbons, Aromatic |
EPHX1 protein polymorphism results in decreased metabolism of Polycyclic Hydrocarbons, Aromatic | decreases metabolic processing | 15917149
|
D011084 |
Polycyclic Hydrocarbons, Aromatic |
EPHX1 protein polymorphism results in increased metabolism of Polycyclic Hydrocarbons, Aromatic | increases metabolic processing | 15917149
|
C045950 |
propiconazole |
propiconazole affects the expression of EPHX1 mRNA | affects expression | 17383973
|
C031280 |
pyrazole |
pyrazole results in increased expression of EPHX1 mRNA | increases expression | 17945193
|
D011794 |
Quercetin |
[Quercetin co-treated with Ascorbic Acid] results in decreased expression of EPHX1 mRNA | affects cotreatment|decreases expression | 17639512
|
D011794 |
Quercetin |
Quercetin results in increased expression of EPHX1 mRNA | increases expression | 18095365
|
C059514 |
resveratrol |
resveratrol results in increased expression of EPHX1 mRNA | increases expression | 11279601
|
C488333 |
Ro 65-7199 |
Ro 65-7199 results in increased expression of EPHX1 mRNA | increases expression | 14610520
|
C488334 |
Ro 66-0074 |
Ro 66-0074 results in increased expression of EPHX1 mRNA | increases expression | 14610520
|
C009250 |
sevoflurane |
sevoflurane affects the expression of EPHX1 mRNA | affects expression | 15967596
|
D020058 |
Styrene |
EPHX1 gene polymorphism affects the susceptibility to Styrene | affects response to substance | 14751678
|
D020058 |
Styrene |
Styrene results in increased expression of EPHX1 mRNA | increases expression | 16418063
|
C013690 |
styrene oxide |
CYP3A12 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide] | affects hydrolysis|increases reaction | 12051674
|
C013690 |
styrene oxide |
EPHX1 protein affects the hydrolysis of styrene oxide | affects hydrolysis | 11076696
|
C013690 |
styrene oxide |
EPHX1 protein affects the metabolism of and results in decreased activity of styrene oxide | affects metabolic processing|decreases activity | 12694745
|
C013690 |
styrene oxide |
EPHX1 protein results in increased hydrolysis of styrene oxide | increases hydrolysis | 17151961
|
C013690 |
styrene oxide |
CYP1A1 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide] | affects hydrolysis|increases reaction | 12051674
|
C013690 |
styrene oxide |
CYP2B1 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide] | affects hydrolysis|increases reaction | 12051674
|
C013690 |
styrene oxide |
CYP2C11 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide] | affects hydrolysis|increases reaction | 12051674
|
C013690 |
styrene oxide |
CYP3A12 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide] | affects hydrolysis|increases reaction | 12051674
|
C016766 |
sulforafan |
[sulforafan co-treated with dibenzoylmethane] results in increased expression of EPHX1 mRNA | affects cotreatment|increases expression | 17942926
|
C016766 |
sulforafan |
sulforafan results in increased expression of EPHX1 mRNA | increases expression | 17942926
|
C446685 |
systhane |
systhane affects the expression of EPHX1 mRNA | affects expression | 17383973
|
D015085 |
2,4,5-Trichlorophenoxyacetic Acid |
2,4,5-Trichlorophenoxyacetic Acid results in increased activity of EPHX1 protein | increases activity | 3032197
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of EPHX1 mRNA | affects expression | 14699072
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of EPHX1 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of EPHX1 mRNA | affects cotreatment|decreases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of EPHX1 mRNA | increases expression | 15328365 15800033 16960034 16611356 18163543
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of EPHX1 mRNA | increases expression | 16960034
|
C019107 |
tetramethylthiourea |
tetramethylthiourea results in increased expression of EPHX1 mRNA | increases expression | 10190572
|
C019107 |
tetramethylthiourea |
tetramethylthiourea results in increased expression of EPHX1 protein | increases expression | 10190572
|
D013844 |
Thiazoles |
Thiazoles results in increased expression of EPHX1 mRNA | increases expression | 8951341
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of EPHX1 mRNA | affects expression | 21346803
|
D014315 |
Triterpenes |
Triterpenes results in increased expression of EPHX1 mRNA | increases expression | 18544911
|
C025643 |
vinclozolin |
vinclozolin affects the expression of EPHX1 mRNA | affects expression | 19015723
|
D014859 |
Warfarin |
EPHX1 gene SNP affects the susceptibility to Warfarin | affects response to substance | 15900282
|
D015032 |
Zinc |
Zinc results in increased expression of EPHX1 mRNA | increases expression | 17074742
|
D019287 |
Zinc Sulfate |
Zinc Sulfate results in increased expression of EPHX1 mRNA | increases expression | 17074742
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.62 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
marker/mechanism |
|
| 2336087 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
26.19 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
26.19 | 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Diethylhexyl Phthalate |
26.19 | 6734493 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
26.19 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenytoin |
26.19 | 6195326 9677735 10563481 3425630 8986270 9118846 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
26.19 | 14514962 11752688 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
26.19 | 7525203 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
7.60 | 18287403 |
MESH:D000138 |
Acidosis |
|
Zinc Sulfate |
7.60 | 7265320 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.01 | 17505938 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
4.49 | 17202136 17190629 16889938 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
6.14 | 12690470 17670903 15814532 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
6.14 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.28 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
9,10-Dimethyl-1,2-benzanthracene |
24.93 | 12844480 10697514 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
24.93 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
24.93 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
24.93 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
24.93 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
24.93 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
24.93 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
24.93 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
24.93 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
24.93 | 11473722 |
MESH:D000236 |
Adenoma |
|
2-Acetylaminofluorene |
26.39 | 10737359 |
MESH:D000236 |
Adenoma |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
26.39 | 16176798 |
MESH:D000236 |
Adenoma |
|
9,10-Dimethyl-1,2-benzanthracene |
26.39 | 11376689 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
26.39 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
26.39 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
26.39 | 19555203 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
26.39 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
26.39 | 15688382 |
MESH:D002759 |
Adenoma, Bile Duct |
|
2-Acetylaminofluorene |
5.07 | 6705139 |
MESH:D018248 |
Adenoma, Liver Cell |
|
dicyclanil |
23.14 | 17162532 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
23.14 | 19061943 17162532 17620307 19052882 18056438 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
23.14 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
23.14 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
23.14 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
dibenzoylmethane |
8.09 | 17942926 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
sulforafan |
8.09 | 17942926 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
2,4-Dichlorophenoxyacetic Acid |
4.24 | 16132792 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
3.67 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.83 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.83 | 16162502 16183991 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
4.83 | 16410023 17119284 16580781 16325427 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.60 | 15469931 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
5.99 | 16511603 17963324 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
5.99 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
3.62 | 14761424 11369114 17661222 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.41 | 17084956 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.02 | 16916123 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
2.91 | 10982225 |
MESH:D000860 |
Anoxia |
|
Zinc Sulfate |
4.11 | 7265320 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
2.88 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.18 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
7.21 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
7.21 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
5.21 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
5.21 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.27 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
3.86 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Zinc |
3.86 | 17085522 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.06 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Asbestos |
10.63 | 18795166 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
10.63 | 15687053 |
MESH:D050197 |
Atherosclerosis |
|
Phenytoin |
10.63 | 15136057 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
10.63 | 16873680 17967414 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Phthalic Acids |
3.68 | 20106747 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.30 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Glutathione |
2.30 | 19267885 16917939 19056591 18929414 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
8.30 | 19761891 |
MESH:D001327 |
Autoimmune Diseases |
|
sulforafan |
8.30 | 19761891 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
3.58 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
15.19 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Clofibrate |
15.19 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
15.19 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.19 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
2.86 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.10 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.30 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
8.97 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
8.97 | 14601052 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.06 | 14991843 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
3.80 | 17109824 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.38 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
1,3-butadiene |
18.81 | 16860786 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
18.81 | 16187019 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
18.81 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylene Oxide |
18.81 | 12562636 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
18.81 | 16357521 16651633 15144691 16436596 18412241 |
MESH:D001943 |
Breast Neoplasms |
|
1,3-butadiene |
25.74 | 11921183 12165863 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
25.74 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
25.74 | 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
25.74 | 15565634 16153821 17127718 18840765 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
25.74 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
25.74 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
25.74 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
25.74 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
25.74 | 17020986 18234424 15136595 11325840 15093573 17388661 16978400 12006526 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
25.74 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
25.74 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
25.74 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
25.74 | 16096432 15692762 16264153 15567936 18628466 16826403 18695136 17426702 15994142 19526202 15136595 15668708 18382427 15634643 15939500 15993339 16935488 17983394 18234424 11325840 16115903 16595493 17369602 16322301 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
25.74 | 12948864 17261762 17289903 16675129 18497071 17018787 14630087 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Ethylene Oxide |
25.74 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
25.74 | 19217205 16110121 15136595 18357371 16557594 16595493 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
25.74 | 16873071 16541309 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Hexachlorobenzene |
25.74 | 12709520 15061365 |
MESH:D001943 |
Breast Neoplasms |
|
Organoselenium Compounds |
25.74 | 15833885 16155795 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
25.74 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
25.74 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Styrene |
25.74 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
25.74 | 20135344 19115204 20065188 18351453 19066611 19155303 17242785 15668708 16818667 19487384 18821012 18815881 18984771 19084267 20005174 19011961 18997820 19142967 11161223 18629630 17440819 19221464 19059307 19189212 19289846 19189210 19288272 15565566 20859285 16202921 19410462 20544844 16273361 17049068 19244106 18855134 18425577 17893378 20390343 21138602 16873071 19103187 21152245 17261762 19200415 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
25.74 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
2.93 | 18315731 17626835 18417511 14754758 15516495 16777450 19059883 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.47 | 11589617 |
MESH:D002100 |
Cachexia |
|
Ozone |
3.83 | 16183385 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.61 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.55 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
2.89 | 3786805 15700767 16050911 16227642 18705752 15721981 16097048 15673190 16011737 16124888 16192424 10355542 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
9.27 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
9.27 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
9.61 | 19555203 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
9.61 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
9.61 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.61 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
46.76 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
46.76 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-Acetylaminofluorene |
46.76 | 17761372 6705139 3581430 10737359 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
46.76 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
46.76 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
46.76 | 15553829 16217749 11135700 14691202 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
46.76 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
46.76 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
46.76 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
dicyclanil |
46.76 | 17162532 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
46.76 | 19519916 16878318 18056438 20727157 19418558 16569478 18978308 20514400 19394651 18210153 17428255 19919837 20084675 19701751 18971187 16935385 20101231 20214788 19822196 3084413 20512989 19208518 16540662 18393292 11831363 16502159 10737359 18788625 19335982 19539802 16698587 16328049 20432363 19052882 19383236 20524982 21159647 17173139 3581430 17761372 18691550 16288022 18494052 19171122 19107877 20007298 17162532 17978847 10672840 18506893 16779866 17138121 16830150 17055752 16807293 18665156 16681979 20935162 18785209 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
46.76 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
46.76 | 18059187 16234567 17876044 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
46.76 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
46.76 | 18930000 16332177 17971768 17045692 16799960 17088986 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
46.76 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
46.76 | 20007298 20935162 17173139 6705139 1701930 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
46.76 | 12508355 19519916 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
46.76 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
46.76 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
8.46 | 16152834 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
8.46 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
2.63 | 16685392 12023789 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.06 | 17234771 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
3.94 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
7.76 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
7.76 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
7.76 | 18695887 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.30 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
9,10-Dimethyl-1,2-benzanthracene |
29.32 | 11376689 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
29.32 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
29.32 | 17066447 18337622 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
29.32 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
29.32 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
29.32 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
erythritol anhydride |
29.32 | 10925838 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
29.32 | 16757204 16280240 17066447 18986760 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Glutathione |
29.32 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
29.32 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
29.32 | 16543248 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
2.80 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
4.80 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
4.80 | 18670907 18850075 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
2.87 | 16612575 17308081 16278810 17131338 16952015 17351982 15811867 17519947 17924179 15476868 15792986 16364871 17974986 17329180 17007740 15505089 17382496 16109756 17928571 16269455 16242529 18627295 16455267 16651473 16731534 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.53 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
8.27 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
8.27 | 15458977 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
8.27 | 16936243 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
8.84 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
8.84 | 10977129 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
8.84 | 15817613 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
21.30 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
21.30 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Clofibrate |
21.30 | 1399818 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
21.30 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
21.30 | 17174075 21159647 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
21.30 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
21.30 | 16003739 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
8.70 | 4080065 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenytoin |
8.70 | 4080065 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.05 | 17160924 |
MESH:D002543 |
Cerebral Hemorrhage |
|
Warfarin |
4.97 | 11061249 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
6.67 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
6.67 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
9.13 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
9.13 | 16105132 11677210 17681005 17110522 16919318 17333356 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
9.13 | 19176532 |
OMIM:601042 |
CHOREOATHETOSIS/SPASTICITY, EPISODIC |
|
Phenytoin |
4.95 | 11748493 |
MESH:D002971 |
Cleft Lip |
|
Phenytoin |
3.58 | 2227380 |
MESH:D002972 |
Cleft Palate |
|
Phenytoin |
4.51 | 2227380 3877104 1687470 10789828 6862529 6856622 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.51 | 12621046 15340226 16354765 8697196 15668235 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.25 | 16474422 |
MESH:D003103 |
Coloboma |
|
Phenytoin |
4.31 | 9212184 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
10.29 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
10.29 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
10.29 | 15001691 17287894 17725105 17169374 16510598 16340194 18772588 17018589 17172411 17016597 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
10.29 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
10.29 | 19440933 11134977 19056647 17148506 16640504 17191121 15741050 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
10.29 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
7.89 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
7.89 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
7.89 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
7.89 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
7.89 | 18383874 15148649 16282729 18509181 16331619 17401013 18802399 17454858 17695437 14970324 20501625 17094418 16524972 16303861 17594712 17255274 18288408 16391804 18949393 17016601 18448328 15289873 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
7.89 | 18095365 18852136 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
7.89 | 16550006 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
4.54 | 17323712 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
15.73 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Phenytoin |
15.73 | 10627286 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
15.73 | 14669216 17141729 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
15.73 | 15095906 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.09 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
8.60 | 12609071 |
MESH:D023903 |
Coronary Restenosis |
|
Warfarin |
8.60 | 12872399 |
OMIM:122700 |
COUMARIN RESISTANCE |
|
Warfarin |
4.96 | 20579077 20497562 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
7.05 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
7.05 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
7.05 | 9014606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Phenytoin |
7.05 | 9212184 19952982 8986270 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
7.05 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
7.05 | 19302082 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
8.46 | 16002989 12952375 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
8.46 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
13.66 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
13.66 | 18551238 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
13.66 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Glutathione |
3.69 | 19747007 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.06 | 18483878 18372110 18295254 16413132 11948286 12388444 17979934 18093676 12161096 15276878 17010015 16989017 16651033 10498854 15643279 18433785 18710439 12913760 10700343 16614059 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
3.88 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.24 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.46 | 19031437 |
MESH:D003872 |
Dermatitis |
|
Benzene |
3.87 | 15902427 |
MESH:D003876 |
Dermatitis, Atopic |
|
Diethylhexyl Phthalate |
5.19 | 16882537 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
5.19 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
3.41 | 16479319 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
9.58 | 10990075 15331540 11751995 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
9.58 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
9.58 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
4.89 | 18772604 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Warfarin |
4.89 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
7.37 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
7.37 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
7.37 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
7.37 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
15.00 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
15.00 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
15.00 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Warfarin |
15.00 | 12644472 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
9.43 | 11748493 |
OMIM:607208 |
DRAVET SYNDROME |
|
Phenytoin |
9.43 | 11748493 |
MESH:D003875 |
Drug Eruptions |
|
Phenytoin |
10.01 | 15024534 |
MESH:D003875 |
Drug Eruptions |
|
Warfarin |
10.01 | 14723717 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
3.77 | 20216337 16538176 15057820 16538175 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
40.04 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
40.04 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2-nitropropane |
40.04 | 16445897 15804453 20517888 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
40.04 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
40.04 | 19923254 10915739 14550746 12705907 2444490 11739529 12594235 18071297 10774834 16177239 12153990 16109766 12540782 19085960 16393943 16081117 19370779 19416960 11529661 11461765 17562736 15968718 16485898 11834606 10663392 16227642 19164858 16781746 15619225 11743745 17522070 14986274 19420014 17906064 12392966 18713872 12958197 14725611 11421492 11287661 19739265 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
bromobenzene |
40.04 | 10092053 12628495 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
40.04 | 17465707 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
40.04 | 16177239 3732212 16227642 7120509 17522070 6623471 19085960 6884620 10915739 3786805 21278145 15998439 4309450 7179309 2869522 15027814 19336974 10092053 9327722 7440962 15968718 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
40.04 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
40.04 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
40.04 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
40.04 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
40.04 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
pyrazole |
40.04 | 12499123 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
40.04 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
40.04 | 18551238 21346803 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.17 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
13.72 | 20216337 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
13.72 | 15033597 12231392 19839026 12649298 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
13.72 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
13.72 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Clofibrate |
3.35 | 16707586 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.15 | 1851702 |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
4.54 | 9068938 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.05 | 18357618 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
9.79 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
pirinixic acid |
9.79 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
9.79 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
9.79 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
2.97 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
19.63 | 17654737 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
19.63 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Phenytoin |
19.63 | 17654737 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
19.63 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
19.63 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.18 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
8.86 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
8.86 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
16.28 | 16804899 15700306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
16.28 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
16.28 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
16.28 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
16.28 | 16202921 20544844 17893378 19155303 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.21 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.22 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
3.95 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.34 | 11006010 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
8.82 | 16538176 18855540 19915237 20485159 16415921 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Phenytoin |
8.82 | 20235791 |
MESH:D004820 |
Epidermolysis Bullosa |
|
Phenytoin |
5.30 | 1399206 6251365 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
8.22 | 17275665 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
8.22 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
11.78 | 17116037 16628512 15008574 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
11.78 | 11558140 3922381 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenytoin |
11.78 | 11558140 17116037 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
7.97 | 17178248 20417680 18234410 17465707 7988514 821787 19700373 19439326 19620853 9014606 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
7.97 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Phenytoin |
7.97 | 11434505 20417680 821787 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
2.75 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
14.41 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
14.41 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenytoin |
14.41 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
12.77 | 15276670 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
12.77 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenytoin |
12.77 | 3659116 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
4.81 | 19549232 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.18 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
12.74 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
12.74 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
12.74 | 15173087 16481741 17638652 16785472 15464296 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
12.74 | 17016578 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
12.74 | 15173087 17638652 16337965 16481741 16785472 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
12.74 | 16543248 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
4.55 | 20485159 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.28 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
33.57 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
33.57 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
33.57 | 19224547 17595544 61145 16239168 15959796 16045604 12795759 12631006 |
MESH:D005234 |
Fatty Liver |
|
Clofibrate |
33.57 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
33.57 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
33.57 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
33.57 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
33.57 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
33.57 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
6.07 | 15751030 16513791 16002989 16534752 16611131 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
6.07 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Phenytoin |
7.78 | 10627286 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
7.78 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.61 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
8.41 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
8.41 | 19069698 |
MESH:D005355 |
Fibrosis |
|
arsenite |
18.42 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
18.42 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
18.42 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
18.42 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
18.42 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.39 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
8.09 | 16983495 |
MESH:D005756 |
Gastritis |
|
Zinc |
8.09 | 17241300 |
MESH:D006471 |
Gastrointestinal Hemorrhage |
|
Warfarin |
5.78 | 11794436 |
MESH:D005776 |
Gaucher Disease |
|
Warfarin |
5.08 | 12359135 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.02 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.37 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.03 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
9.87 | 8708960 |
MESH:D005885 |
Gingival Hyperplasia |
|
Phenytoin |
9.87 | 9029455 |
MESH:D019214 |
Gingival Overgrowth |
|
Phenytoin |
5.30 | 14659971 16390469 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
15.23 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
15.23 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
15.23 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
15.23 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
15.23 | 19804834 |
MESH:D005910 |
Glioma |
|
1,3-butadiene |
10.27 | 15814359 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
10.27 | 18412241 16357521 16651633 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
10.27 | 16145905 |
MESH:D005910 |
Glioma |
|
Quercetin |
10.27 | 17643826 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
4.60 | 11389073 |
MESH:D005922 |
Glomerulonephritis, IGA |
|
deoxynivalenol |
4.25 | 16524712 15173396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.66 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.14 | 16376943 15172196 11014644 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.30 | 17217573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
12.88 | 15102660 15464296 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
12.88 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
12.88 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
12.88 | 15162350 15102660 18337622 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
7.82 | 19898482 |
MESH:D034381 |
Hearing Loss |
|
Styrene |
7.82 | 17420221 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
3.63 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
7.82 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
7.82 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
7.82 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
2.80 | 16244371 17875725 18674790 16495754 16707910 16879835 16144979 18006777 12587719 16244372 16330681 14766674 17888722 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
8.14 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
8.14 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Zinc |
8.14 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
4.84 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
3.68 | 17241300 |
MESH:D006390 |
Hemangioendothelioma |
|
2-Acetylaminofluorene |
4.39 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
1,3-butadiene |
10.73 | 10930038 2208121 |
MESH:D006394 |
Hemangiosarcoma |
|
2-Acetylaminofluorene |
10.73 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
10.73 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
3.80 | 16183116 |
MESH:D006406 |
Hematoma |
|
Warfarin |
5.78 | 17493413 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.50 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.39 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
7.73 | 11000095 |
MESH:D006470 |
Hemorrhage |
|
Warfarin |
7.73 | 18429757 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
4.60 | 14986274 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
2.73 | 19110552 19900420 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
8.35 | 17276780 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc Sulfate |
8.35 | 17063115 |
MESH:D006529 |
Hepatomegaly |
|
fenvalerate |
37.21 | 15602828 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
37.21 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
37.21 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
37.21 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
37.21 | 18467677 16221962 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
propiconazole |
37.21 | 17178689 17178688 |
MESH:D006529 |
Hepatomegaly |
|
systhane |
37.21 | 17178689 17178688 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
37.21 | 15340226 16120746 12621046 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
37.21 | 15817613 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
3.06 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.10 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.28 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
7.90 | 16200630 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
7.90 | 17606976 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
7.90 | 18501091 17606976 15147373 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
2.83 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.11 | 8697196 16959395 15340226 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
5.36 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
5.36 | 12083418 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.62 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.18 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
6.54 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
6.54 | 11834736 18262572 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
7.26 | 10459572 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Phenytoin |
7.26 | 10459572 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.19 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
13.51 | 18773962 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
13.51 | 12960047 14722030 |
MESH:D006965 |
Hyperplasia |
|
halofuginone |
13.51 | 11874485 |
MESH:D006973 |
Hypertension |
|
Benzene |
8.53 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.53 | 10903974 |
MESH:D006973 |
Hypertension |
|
Quercetin |
8.53 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.53 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.19 | 15338365 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Warfarin |
4.10 | 12359135 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.48 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
8.27 | 16002989 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
8.27 | 16945680 16569931 |
MESH:D007022 |
Hypotension |
|
Zinc Sulfate |
3.63 | 7265320 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
4.40 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
3.75 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.48 | 15036965 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.61 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
2,4-Dichlorophenoxyacetic Acid |
17.66 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
17.66 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
17.66 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
17.66 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
17.66 | 12150543 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
17.66 | 16467254 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
9.82 | 18785209 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
9.82 | 12083418 |
MESH:D007249 |
Inflammation |
|
resveratrol |
9.82 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
9.82 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.82 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
8.12 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
8.12 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
4.97 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
4.97 | 16306350 |
MESH:D007511 |
Ischemia |
|
Zinc |
3.74 | 16584753 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.50 | 16580747 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.06 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.51 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.21 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
27.02 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
27.02 | 16322080 16226777 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
27.02 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
27.02 | 19839026 15190930 12649298 12231392 18289764 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
27.02 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
27.02 | 15699352 16775033 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
27.02 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
27.02 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
27.02 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
7.41 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
7.41 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
27.67 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
27.67 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
27.67 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
27.67 | 15003126 16762066 14681315 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
27.67 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
27.67 | 17379185 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
27.67 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
27.67 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
3.87 | 11231351 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
7.05 | 17184923 |
MESH:D007859 |
Learning Disorders |
|
sevoflurane |
7.05 | 19212262 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Zinc Sulfate |
3.50 | 15237267 |
MESH:D007938 |
Leukemia |
|
1,3-butadiene |
21.19 | 16155477 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
21.19 | 15070760 |
MESH:D007938 |
Leukemia |
|
Benzene |
21.19 | 14694614 17119257 18335105 15935818 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
21.19 | 10602166 |
MESH:D007938 |
Leukemia |
|
decitabine |
21.19 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Genistein |
21.19 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
21.19 | 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.22 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.01 | 17296974 17802794 17658394 18587576 17008537 18172266 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
2.96 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.39 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
6.19 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
6.19 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
11.28 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
11.28 | 17506065 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
11.28 | 17236224 19117987 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
4.61 | 20471514 17050201 19850784 16467208 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
4.61 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.61 | 19387464 18460780 18704418 19010910 18206229 17679729 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
4.53 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
5.56 | 15213294 16331271 17649720 17869043 19075265 16966277 12712474 15622746 19035177 12018890 9834237 19225113 16891316 17217047 12679006 15336539 16823087 11161223 17712046 15748426 19642359 16330433 17107899 11468182 16112521 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
5.56 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.47 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.05 | 11830472 10052129 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
9.90 | 8812269 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
9.90 | 16417039 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.46 | 17567588 15342952 |
MESH:D054068 |
Livedo Reticularis |
|
Warfarin |
5.78 | 18280355 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
14.42 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
14.42 | 17174718 16943688 17157831 21278145 16221502 11408273 16239168 17334410 11903743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
14.42 | 20032147 18407596 18522880 19638242 18665156 |
MESH:D008103 |
Liver Cirrhosis |
|
halofuginone |
14.42 | 17180598 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
14.42 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
1,3-dimethylthiourea |
15.72 | 11682029 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
15.72 | 18395095 18054572 12667390 15818738 12632514 18412020 18156304 17761835 15893842 14748882 18317297 18210741 16011737 18395914 17721639 15338365 18339082 18472332 12958196 17714472 11481614 16248980 13678700 18251166 12741479 12666154 12632512 18376398 17565644 17823541 18420326 16015684 17557913 14716496 18205269 12445418 17640975 17708605 18279442 18277467 18705752 17805973 15876570 17869086 16116963 17900296 12586293 15931870 10355542 16638106 15996030 12649538 12546737 14620537 12609069 16033810 15123356 16097048 15673190 18006644 17525996 15052691 18429990 17698563 15650968 15925388 20821823 14512876 17976157 15370692 17766677 17481882 12898905 18472094 14716833 17922224 15057751 16136751 18263696 12389079 17631135 17944888 18166357 18418968 14724832 15959796 16027843 16192424 15362042 18481824 12445421 18187930 15730626 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
15.72 | 17640959 18364076 15842777 15369754 15733078 15504291 16270385 15383259 15366600 15723089 18371158 18637143 17534399 17203207 12925901 16009107 15798949 17724770 15161499 16627068 12918455 16603200 15339415 15577212 15086199 15081153 15864749 18239293 15067225 14643895 16042886 14726149 15942678 16570917 18210741 15744066 17719030 15793283 15479170 15763062 15492853 15571005 17666798 17201889 16544323 18567088 14659978 14568256 15298665 17432682 17465448 16169303 14709902 17198567 17881167 15591649 17196135 18629640 17348192 15099470 18672772 17036385 18237412 15138612 18095165 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
15.72 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
15.72 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
15.72 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
halofuginone |
15.72 | 16489207 11172339 12175628 18458672 14739098 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
15.72 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
15.72 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
15.72 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
15.72 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
11.14 | 16610002 16611625 19784758 12587719 19460945 11587558 12969438 19014921 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
11.14 | 16246199 16964402 15720792 15830285 17285989 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
11.14 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
11.14 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Phenytoin |
11.14 | 14986274 |
MESH:D008107 |
Liver Diseases |
|
propiconazole |
11.14 | 19363144 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.27 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
11.56 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
11.56 | 16899240 14706259 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
11.56 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
1,3-butadiene |
91.64 | 2208121 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
91.64 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
2-Acetylaminofluorene |
91.64 | 16273603 11376686 14678523 10672840 18001218 10737359 |
MESH:D008113 |
Liver Neoplasms |
|
2-nitrofluorene |
91.64 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
91.64 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
91.64 | 9643874 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
91.64 | 18177683 15890375 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
91.64 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
91.64 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
91.64 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
dicyclanil |
91.64 | 20118626 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylhexyl Phthalate |
91.64 | 11940454 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
91.64 | 18648771 19090486 19690152 19256749 18977376 9163691 19294768 2862719 18644402 20434301 15175105 21167192 19426721 19255062 19254457 20583210 18754104 18978307 20101389 20118626 19499222 10737359 20137499 15885732 19812893 19073162 12112319 21071580 12771043 19642983 16942905 19833225 21278145 20501860 19638242 19850985 19427195 20405173 20452335 21047994 2422723 19551842 20492335 19996281 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
91.64 | 16712894 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
diethylthiourea |
91.64 | 11940454 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
91.64 | 15890375 3113478 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
91.64 | 15113037 17045692 16603448 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
Methapyrilene |
91.64 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
91.64 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
91.64 | 8742319 19812893 19073162 21047994 15975961 19482888 |
MESH:D008113 |
Liver Neoplasms |
|
Piperonyl Butoxide |
91.64 | 19690152 15890375 18648771 20101389 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
91.64 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
propiconazole |
91.64 | 19028983 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
91.64 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
91.64 | 19073162 19812893 19321006 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
91.64 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
91.64 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
77.78 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2-Acetylaminofluorene |
77.78 | 1399818 6150874 534488 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
9,10-Dimethyl-1,2-benzanthracene |
77.78 | 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
77.78 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxins |
77.78 | 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
77.78 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
77.78 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
77.78 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
77.78 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
77.78 | 19539802 17174075 19009564 18308698 18775883 18282651 16267830 21159647 18544905 3124819 18253720 19519916 18164116 17854601 19126423 17942915 18079962 19004024 16842330 18093689 2563599 9362446 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
77.78 | 15603536 1848544 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
77.78 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Hexachlorobenzene |
77.78 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
77.78 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Organoselenium Compounds |
77.78 | 16170372 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
77.78 | 1399818 6150874 17172636 18308698 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
propiconazole |
77.78 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
77.78 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
styrene oxide |
77.78 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
systhane |
77.78 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
77.78 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.62 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
5.54 | 16863852 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
5.54 | 8266340 19066396 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
3.88 | 14698565 |
MESH:D055370 |
Lung Injury |
|
Ozone |
2.97 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
1,3-butadiene |
49.97 | 2208121 17372256 16860786 |
MESH:D008175 |
Lung Neoplasms |
|
2-Acetylaminofluorene |
49.97 | 11376686 |
MESH:D008175 |
Lung Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
49.97 | 19931552 16061637 18508827 16401635 14755239 15172992 15893417 17139156 12438228 9255578 18813816 |
MESH:D008175 |
Lung Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
49.97 | 11376689 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
49.97 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
49.97 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
49.97 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Asbestos |
49.97 | 12111688 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
49.97 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
49.97 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
49.97 | 20464547 20064080 18569708 18520028 18816296 20869020 20135361 17053015 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
49.97 | 6189445 17225452 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
49.97 | 21163286 20970405 20512841 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
49.97 | 16061637 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
49.97 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylene Oxide |
49.97 | 12562636 17325976 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
49.97 | 6695378 16019985 17703301 16271038 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
49.97 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
49.97 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Polycyclic Hydrocarbons, Aromatic |
49.97 | 10814675 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
49.97 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
Styrene |
49.97 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
49.97 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
49.97 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
3.88 | 15086387 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
3.22 | 16628512 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.23 | 15166399 |
MESH:D008223 |
Lymphoma |
|
1,3-butadiene |
28.91 | 11980663 9205081 2208121 17941976 18798262 9488045 8764131 |
MESH:D008223 |
Lymphoma |
|
9,10-Dimethyl-1,2-benzanthracene |
28.91 | 11376689 |
MESH:D008223 |
Lymphoma |
|
Benzene |
28.91 | 17584886 17119257 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
28.91 | 12854902 |
MESH:D008223 |
Lymphoma |
|
decitabine |
28.91 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
28.91 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
28.91 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
28.91 | 15790496 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
7.64 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
7.64 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
2,4-Dichlorophenoxyacetic Acid |
14.43 | 16132792 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
14.43 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
14.43 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
14.43 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
8.72 | 15621674 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
8.72 | 15375218 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.58 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
1,3-butadiene |
27.26 | 2208121 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
27.26 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Ethylene Oxide |
27.26 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
27.26 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Styrene |
27.26 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
27.26 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
1,3-butadiene |
37.49 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
37.49 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
9,10-Dimethyl-1,2-benzanthracene |
37.49 | 8985016 16082771 12844480 18840765 10697514 11807958 16153821 1500032 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
37.49 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
37.49 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
37.49 | 16891317 11807958 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylene Oxide |
37.49 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
37.49 | 10767621 10838139 18041768 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
37.49 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
37.49 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
37.49 | 19196723 14580682 19196722 11731420 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
37.49 | 12773700 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
9.56 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
9.56 | 19453300 |
MESH:D008545 |
Melanoma |
|
Carmustine |
8.92 | 12393984 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
8.92 | 16432458 18332650 17761969 18176117 15577323 12883367 18505091 12393984 17023156 11135225 16809738 12374674 16248763 |
MESH:D008545 |
Melanoma |
|
decitabine |
8.92 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
8.92 | 16827129 |
MESH:D008545 |
Melanoma |
|
resveratrol |
8.92 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
8.92 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
8.48 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
8.48 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
7.87 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
7.87 | 16388313 |
MESH:D008569 |
Memory Disorders |
|
sevoflurane |
3.89 | 19212262 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.05 | 17943659 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
5.10 | 9014606 |
MESH:D008607 |
Mental Retardation |
|
Phenytoin |
5.10 | 9212184 |
MESH:D008654 |
Mesothelioma |
|
Asbestos |
7.62 | 18310086 16564556 16919927 16319530 18709470 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
7.62 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
7.62 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.54 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
3.85 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.17 | 10496685 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
3.66 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
6.05 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
6.05 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
3.88 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
marker/mechanism |
|
| 16949155 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
11.51 | 15949261 14977855 19417148 19549372 11468182 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
11.51 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
11.51 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
11.51 | 17164350 17049120 14749477 16490592 17935668 16267019 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
3.96 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.62 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
3.74 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
5.45 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
5.45 | 19010910 18608210 19157545 16882708 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
12.60 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
12.60 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
12.60 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
12.60 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
12.60 | 16317513 17188708 17125593 16525036 16456233 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
6.47 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
6.47 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
14.20 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
14.20 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
14.20 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
14.20 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
3.85 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
9.46 | 17484760 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenytoin |
9.46 | 17484760 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
9.45 | 20399394 |
MESH:D009224 |
Myotonia Congenita |
|
Phenytoin |
9.45 | 1896199 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
23.80 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
23.80 | 7678174 18551238 |
MESH:D009336 |
Necrosis |
|
2-nitropropane |
23.80 | 12195237 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
23.80 | 18551238 |
MESH:D009336 |
Necrosis |
|
Warfarin |
23.80 | 14723717 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.09 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
6.70 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.70 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
6.70 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.12 | 19410462 |
MESH:D009369 |
Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
25.19 | 11544531 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
25.19 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
25.19 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
25.19 | 18854779 |
MESH:D009369 |
Neoplasms |
|
decitabine |
25.19 | 19116145 17925555 19470736 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
25.19 | 15313581 |
MESH:D009369 |
Neoplasms |
|
fenvalerate |
25.19 | 2895627 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
25.19 | 18600527 18239605 16928823 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
25.19 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
25.19 | 15185748 |
MESH:D009374 |
Neoplasms, Experimental |
|
1,3-butadiene |
14.74 | 9205081 9488045 8764131 |
MESH:D009374 |
Neoplasms, Experimental |
|
erythritol anhydride |
14.74 | 10925838 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
14.74 | 16707424 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
14.74 | 8985016 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.08 | 19196722 19189210 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
7.14 | 15738583 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
7.14 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
3.57 | 15464296 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
3.87 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.51 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
6.65 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
6.65 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
21.62 | 16990009 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
21.62 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
21.62 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
21.62 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
21.62 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
8.49 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
8.49 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
Phenytoin |
8.49 | 9118846 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
4.50 | 16651423 16003739 17160924 |
MESH:D009447 |
Neuroblastoma |
|
1,3-butadiene |
11.65 | 15814359 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
11.65 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
11.65 | 8761367 15176712 16115947 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
11.65 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
9.57 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
9.57 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
9.57 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
8.50 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
8.50 | 8761367 12837982 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
7.86 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
7.86 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.18 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
2.76 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
3.48 | 8291058 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Clofibrate |
9.09 | 9802331 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
9.09 | 9802331 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
3.61 | 17217161 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
3.61 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
19.77 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
19.77 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
19.77 | 14694615 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
19.77 | 15612468 15935809 15576619 15727169 17119257 16737584 17178637 15913788 17479406 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
19.77 | 17852074 12819281 14694615 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.05 | 17160924 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
3.80 | 16517039 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
15.08 | 17016548 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
15.08 | 17016548 |
MESH:D010018 |
Osteomalacia |
|
Phenytoin |
15.08 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
2.63 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
11.98 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
11.98 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
11.98 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.35 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
1,3-butadiene |
26.73 | 2208121 |
MESH:D010051 |
Ovarian Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
26.73 | 16891317 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
26.73 | 12452020 16624393 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
26.73 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
26.73 | 19769630 17225452 6897625 15464296 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
26.73 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
26.73 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
26.73 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Medroxyprogesterone Acetate |
26.73 | 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
26.73 | 19005980 |
MESH:D010146 |
Pain |
|
Acetaminophen |
9.98 | 16870215 |
MESH:D010146 |
Pain |
|
Carbamazepine |
9.98 | 15215642 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
9.98 | 12161096 18093676 |
MESH:D010146 |
Pain |
|
Phenytoin |
9.98 | 15215642 |
MESH:D010190 |
Pancreatic Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
25.00 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
25.00 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
25.00 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
25.00 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
25.00 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
25.00 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
25.00 | 19003803 16929163 15113037 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
25.00 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
25.00 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
2.83 | 11578682 |
MESH:D010212 |
Papilloma |
|
9,10-Dimethyl-1,2-benzanthracene |
4.41 | 16517061 15173996 17234724 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.31 | 19927285 |
MESH:D010243 |
Paralysis |
|
fenvalerate |
5.09 | 8952708 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
4.80 | 16538176 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
5.01 | 17145499 17679678 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.32 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.44 | 15464296 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
4.47 | 15687053 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.24 | 16369182 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.22 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.24 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
3.77 | 15687265 16977796 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
10.85 | 17638057 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
10.85 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.48 | 18007984 18929643 18381685 |
MESH:D017689 |
Polydactyly |
|
Phenytoin |
4.24 | 9212184 |
MESH:D011115 |
Polyneuropathies |
|
Ethylene Oxide |
5.26 | 8472653 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Hexachlorobenzene |
8.20 | 9918132 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
8.20 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
15.38 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
15.38 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
15.38 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
15.38 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.21 | 21297632 |
MESH:D011225 |
Pre-Eclampsia |
marker/mechanism |
|
| |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
3.43 | 17114810 |
MESH:D011248 |
Pregnancy Complications |
|
2,4-Dichlorophenoxyacetic Acid |
8.63 | 2087686 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
8.63 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
marker/mechanism |
|
| |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
26.26 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
26.26 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
26.26 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
26.26 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
26.26 | 11118676 11399792 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
26.26 | 18042343 18220299 19015723 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
3.83 | 17616702 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.02 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.05 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17919073 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
4.53 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
4.53 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
4.53 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
4.53 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
4.53 | 15846301 17136230 15046698 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
4.53 | 16868541 15897917 15749863 18437689 16888761 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
4.53 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
4.53 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
4.53 | 16925846 15256057 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
4.53 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
4.53 | 17675339 16731767 17804756 17718901 17636462 15767336 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
4.53 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
4.53 | 16517595 16606632 12429649 16700911 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.02 | 18629315 |
MESH:D020151 |
Protein C Deficiency |
|
Warfarin |
5.43 | 18376272 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.41 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
15.95 | 9591791 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
15.95 | 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Phenytoin |
15.95 | 8603615 12752131 1419762 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.81 | 16882103 |
MESH:D011655 |
Pulmonary Embolism |
|
Warfarin |
5.43 | 19300499 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
4.40 | 14606601 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
2.85 | 16636934 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.21 | 15538739 18286688 18722050 16160472 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
7.42 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
7.42 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.65 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
4.73 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
4.73 | 16314181 16317513 17058453 15827377 17520802 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
3.40 | 16584753 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
2.96 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
3.55 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.18 | 15675481 15625365 17203757 16767912 17710206 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
12.25 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
12.25 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
12.25 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
3.88 | 17846226 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.61 | 16862918 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
3.96 | 16636934 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
14.51 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
14.51 | 18551238 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
14.51 | 9844417 15946322 16876388 9046859 19414003 16180713 16938433 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
14.51 | 3137016 16876388 11442880 4039156 |
MESH:D012640 |
Seizures |
|
Phenytoin |
14.51 | 16876388 11044598 19919933 10029267 3691417 9844417 15946322 3137016 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
14.51 | 18551238 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
3.90 | 6407741 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Warfarin |
4.97 | 12269725 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
4.42 | 18709164 |
MESH:D012871 |
Skin Diseases |
|
halofuginone |
4.42 | 11874485 |
MESH:D012878 |
Skin Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
12.23 | 15173996 16517061 8985016 11376689 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
12.23 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
12.23 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
12.23 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.23 | 16192470 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
4.21 | 19414003 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.41 | 15464296 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
3.67 | 17203757 15625365 16767912 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
14.78 | 16709447 16002989 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
14.78 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
14.78 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
4.60 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.13 | 19457130 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
4.34 | 12587719 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
4.30 | 15817613 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
8.60 | 19915237 19694795 16538176 18855540 15057820 16415921 20485159 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Phenytoin |
8.60 | 20235791 |
MESH:D013274 |
Stomach Neoplasms |
|
1,3-butadiene |
13.43 | 11397402 2208121 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
13.43 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
13.43 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
13.43 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
13.43 | 17522103 18396642 15958060 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
13.43 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
13.43 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
13.43 | 16033868 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
13.43 | 17522103 18396642 16424979 19015929 17498489 18567086 19084572 16951190 17172411 15786421 |
MESH:D013274 |
Stomach Neoplasms |
|
styrene oxide |
13.43 | 12562636 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
3.12 | 18726076 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
6.89 | 16517955 16403987 |
MESH:D020521 |
Stroke |
|
Warfarin |
6.89 | 19300499 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.66 | 16321402 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.14 | 12837982 |
MESH:D013733 |
Testicular Diseases |
|
pyrazole |
3.91 | 6499806 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
3.77 | 17225452 15464296 |
MESH:D013923 |
Thromboembolism |
|
Warfarin |
5.23 | 16960144 18698879 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
8.18 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Warfarin |
8.18 | 17493413 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
6.78 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Warfarin |
6.78 | 19300499 17672075 15720958 11518727 17245631 11307788 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
9.17 | 10850423 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
9.17 | 15790496 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
2.97 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
18.58 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
18.58 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
18.58 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
diethylthiourea |
18.58 | 11940454 1907225 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
18.58 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
18.58 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
3.75 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
11.96 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
11.96 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
11.96 | 16543248 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.06 | 15213294 |
MESH:D014202 |
Tremor |
|
fenvalerate |
4.64 | 8952708 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
34.50 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
34.50 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Acetylaminofluorene |
34.50 | 1399818 15289314 15867355 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
34.50 | 20435036 12973940 11780464 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
34.50 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
34.50 | 12973940 17225452 15464296 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
34.50 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
34.50 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
34.50 | 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
34.50 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
34.50 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
34.50 | 17572228 16712894 8653321 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
8.96 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
8.96 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.14 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
16.03 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
16.03 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
16.03 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
16.03 | 17473185 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.24 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
20.89 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
20.89 | 15809267 16690809 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
20.89 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethylene Oxide |
20.89 | 17325976 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
20.89 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
3.98 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.05 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
8.12 | 15577323 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
8.12 | 16002989 16513791 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.66 | 12125929 |
MESH:D014657 |
Vasculitis |
|
Warfarin |
4.97 | 20337814 |
MESH:D054556 |
Venous Thromboembolism |
|
Warfarin |
5.43 | 18776969 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
7.96 | 15869587 14671159 |
MESH:D020246 |
Venous Thrombosis |
|
Warfarin |
7.96 | 14723717 15733061 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
7.38 | 16364871 17334414 17638931 17678736 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
7.38 | 17488730 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
3.79 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.32 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.51 | 17120751 |